The mass launch of a Covid-19 vaccine in Britain could be completed in as little as three months, the Times reported, citing government scientists. Scientists working on the Oxford vaccine hope that regulators will approve it before early 2021, the newspaper said. A full Covid-19 immunization schedule, which would exclude …
Read More »
NEW DELHI: Dr. Reddy‘s Laboratories applied to the Comptroller General of Drugs of India for permission to conduct phase 3 human clinical trials of the Russian Sputnik V vaccine against Covid-19 in India, the sources said. The Indian pharmaceutical giant has collaborated with the Russian Direct Investment Fund (RDIF) to …
Read More »
NEW DELHI: The government may need ₹Rs 80 billion over the next year for the distribution of the covid-19 vaccine to all people in India, Serum Institute of India Executive Director Adar Poonawalla said on Saturday, calling it a “worrying challenge.” “Will the government of India have Rs 80 billion …
Read More »
NEW DELHI: No vaccine for respiratory diseases it is 100% effective and those that are 50-100% effective can be approved for use against the Covid-19 pandemic, Indian Council of Medical Research (ICMR), Dr. Balram Bhargava, CEO, said even when adding that maximum efficacy will be sought. “No vaccine for respiratory …
Read More »
A vaccine for the coronavirus is likely to be ready in early 2021, but safely deploying it to India’s 1.3 billion people will be the country’s biggest challenge in fighting its growing epidemic, a leading vaccine scientist told Bloomberg. India, which is home to some of the cutting-edge vaccine clinical …
Read More »
PUNE: The phase III human clinical trial of the Covid-19 vaccine developed by the University of Oxford and being manufactured by the Serum Institute of India (SII) will begin at Sassoon General Hospital in Pune next week. Sassoon General Hospital Dean Dr. Muralidhar Tambe told PTI this on Saturday. “The …
Read More »
Representative image NEW DELHI: The government is considering the emergency authorization of Covid-19 vaccine so that it can be made available as soon as possible to those in high-risk groups, including the elderly and health workers, Health Minister Harsh Vardhan said. “This will be done after a consensus is reached,” …
Read More »
NEW DELHI: The Controller General of Medicines of India (DCGI) has directed the Serum Institute of India to suspend until new hires are ordered in the phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate in the context of the pharmaceutical giant AstraZeneca stopping trials in other …
Read More »
A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that led to a pause in testing, a spokesman for the pharmaceutical AstraZeneca said on Thursday. The study participant in the late-stage trials reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, company spokesman …
Read More »
Representative image NEW DELHI/ MUMBAI: Serum Institute of India stopped the Covishield trials, Oxford University-AstraZenecaCandidate for the Covid-19 vaccine, after a notice issued by the central drug regulator. “We are reviewing the situation and stopping the trials in India until AstraZeneca restarts them. We are following the instructions of the …
Read More »